‘Supporting the era of green pharmaceuticals in the UK’ highlights that, while Britain can play a leading role in the sustainability agenda for pharmaceuticals, action must also be taken on a global scale to ensure impact.
The pharmaceutical industry’s share of health service carbon emissions is estimated to be between 12% and 35%, different studies taking different measures of the NHS carbon footprint as the total. Nonetheless, the majority of emissions (70% to 90%) of most pharma companies lay outside their direct control, though they have made commitments to play a part in reaching net zero targets.
